Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Clinical trial NCT06369610 · RECRUITING

Trial details

NCT number: NCT06369610
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oligometastatic Prostate Carcinoma Prostate Adenocarcinoma

Start date: 2024-04-22
Primary completion: 2027-04-22
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.